原代细胞的全球市场

Primary Cells

出版日期: 2024年08月29日 | 出版商:

Global Industry Analysts, Inc. | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2030年全球原电池市场将达18亿美元

全球原电池市场预计 2023 年为 11 亿美元，预计到 2030 年将达到 18 亿美元，2023-2030 年分析期间复合年增长率为 7.1%。人类原代细胞是本报告分析的细分市场之一，预计复合年增长率为 7.4%，到分析期结束时将达到 14 亿美元。在分析期间，动物原代细胞领域的复合年增长率预计为 5.7%。

美国市场预估成长2.982亿美元，中国复合年增长率为6.7%

预计 2023 年美国原电池市场规模将达 2.982 亿美元。中国作为全球第二大经济体，预计2030年市场规模将达2.726亿美元，2023年至2030年复合年增长率为6.7%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 6.6% 和 5.7%。在欧洲，德国预计复合年增长率为 5.8%。

全球原电池市场 - 主要趋势和驱动因素总结

原代细胞：生物医学研究和药物开发的重要工具

原代细胞是直接取自活组织并在试管内培养的细胞，保留了原始组织的许多生理特征和功能。与永生化细胞株係不同，原代细胞的寿命有限，因为它们被设计为无限增殖，并且非常模仿体内细胞的行为。这些细胞是生物医学研究、毒理学研究和药物开发的重要工具，用于研究正常和病理细胞功能、筛检潜在候选药物和疾病模型。原代细胞来自多种组织，包括血液、皮肤、肝臟和大脑，可以透过培养来创建特定器官和系统的模型。原代细胞提供比细胞株更准确和相关的资料，这使得它们对于寻求了解复杂生物过程和开发有效治疗方法的研究人员很有价值。

科技进步如何增强原代细胞及其应用？

技术进步显着改善了原代细胞的分离、培养和应用，使其可用于广泛的研究和开发。细胞分离技术的创新，例如萤光激活细胞分选（FACS）和磁激活细胞分选（MACS），提高了获得具有特定性质的纯原代细胞群的能力，从而提高了实验结果的可靠性和可靠性。先进培养基和补充品的发展延长了试管内原代细胞的寿命，允许更长的实验和更全面的研究。此外，3D细胞培养技术和器官晶片系统的整合使得能够使用原代细胞创建更多生理相关模型，从而提供对组织功能和疾病机制的更深入的了解。这些技术进步扩大了原代细胞的应用和益处，使其成为尖端生物医学研究和药物发现的重要工具。

原代细胞的主要用途和优点是什么？

原代细胞用于各种研究和开发应用，并具有许多优点，可提高科学研究的准确性和有效性。在药物开发中，原代细胞用于筛检潜在候选药物的功效和毒性，为药物在人体内如何发挥作用提供更可靠的资料。在疾病建模中，原代细胞用于创建癌症、神经退化性疾病和循环系统疾病等试管内疾病模型，使研究人员能够在受控环境中研究疾病机制并测试潜在的治疗方法。在个人化医疗中，从个别患者获得的原代细胞用于开发客製化治疗方法并预测患者对特定药物的反应。使用原代细胞的主要优点包括它们能够忠实地模拟体内条件，提供比细胞株更准确的资料，并提供对复杂生物过程的洞察。原代细胞透过提供适当且可靠的模型系统，在推进生物医学研究和开发新治疗方法方面发挥重要作用。

推动原代细胞市场成长的因素有哪些？

原代细胞市场的成长受到多种因素的推动。一个关键的驱动因素是生物医学研究和药物开发中对更多生理相关模型的需求不断增加，因为与细胞株相比，原代细胞可以更准确地代表体内条件。改善原代细胞分离、培养和应用的技术进步也在推动市场成长。对个人化医疗的日益关注以及药物开发中对患者特异性模型的需求进一步推动了对原代细胞的需求。此外，癌症、免疫学和神经科学等领域研究活动的扩大也促进了原代细胞市场的成长，原代细胞对于研究复杂的生物系统至关重要。商业供应商提供的高品质原代细胞以及先进培养系统的使用不断增加也推动了市场的扩张。这些因素，加上细胞培养技术的不断创新，正在推动原代细胞市场的持续成长。

调查企业举例（共22家）

Allcells LLC
American Type Culture Collection（ATCC）
Axol Bioscience Ltd.
Cell Biologics, Inc.
Lonza Group AG
Merck KgaA
Promocell GmbH
Thermo Fisher Scientific, Inc.
Zenbio, Inc.

The global market for Primary Cells estimated at US$1.1 Billion in the year 2023, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2023-2030. Human Primary Cells, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Animal Primary Cells segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$298.2 Million While China is Forecast to Grow at 6.7% CAGR

The Primary Cells market in the U.S. is estimated at US$298.2 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$272.6 Million by the year 2030 trailing a CAGR of 6.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.6% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Global Primary Cells Market - Key Trends and Drivers Summarized

Primary Cells: Essential Tools for Biomedical Research and Drug Development

Primary cells are cells taken directly from living tissue and cultured in vitro, retaining many of the physiological characteristics and functions of the original tissue. Unlike immortalized cell lines, which are modified to proliferate indefinitely, primary cells have a limited lifespan and closely mimic the behavior of cells in the body. These cells are essential tools in biomedical research, toxicology studies, and drug development, where they are used to study normal and pathological cell functions, screen potential drug candidates, and model diseases. Primary cells are derived from various tissues, including blood, skin, liver, and brain, and can be cultured to create models of specific organs or systems. Their ability to provide more accurate and relevant data than cell lines makes primary cells invaluable for researchers seeking to understand complex biological processes and develop effective therapies.

How Are Technological Advancements Enhancing Primary Cells and Their Applications?

Technological advancements have significantly improved the isolation, culture, and application of primary cells, making them more accessible and useful for a wide range of research and development activities. Innovations in cell isolation techniques, such as fluorescence-activated cell sorting (FACS) and magnetic-activated cell sorting (MACS), have enhanced the ability to obtain pure populations of primary cells with specific characteristics, improving the reliability and reproducibility of experimental results. The development of advanced culture media and supplements has extended the lifespan of primary cells in vitro, allowing for longer experiments and more comprehensive studies. Additionally, the integration of 3D cell culture technologies and organ-on-a-chip systems has enabled the creation of more physiologically relevant models using primary cells, providing better insights into tissue function and disease mechanisms. These technological improvements have expanded the applications and benefits of primary cells, making them essential tools in cutting-edge biomedical research and drug discovery.

What Are the Key Applications and Benefits of Primary Cells?

Primary cells are used in a variety of research and development applications, offering numerous benefits that enhance the accuracy and relevance of scientific studies. In drug development, primary cells are used to screen potential drug candidates for efficacy and toxicity, providing more reliable data on how a drug will behave in the human body. In disease modeling, primary cells are used to create in vitro models of diseases such as cancer, neurodegenerative disorders, and cardiovascular conditions, allowing researchers to study disease mechanisms and test potential therapies in a controlled environment. In personalized medicine, primary cells derived from individual patients are used to develop customized treatments and predict patient responses to specific drugs. The primary benefits of using primary cells include their ability to closely mimic in vivo conditions, provide more accurate data than cell lines, and offer insights into complex biological processes. By providing a relevant and reliable model system, primary cells play a critical role in advancing biomedical research and developing new therapies.

What Factors Are Driving the Growth in the Primary Cells Market?

The growth in the primary cells market is driven by several factors. The increasing demand for more physiologically relevant models in biomedical research and drug development is a significant driver, as primary cells offer a more accurate representation of in vivo conditions compared to cell lines. Technological advancements that improve the isolation, culture, and application of primary cells are also propelling market growth. The rising focus on personalized medicine and the need for patient-specific models in drug development are further boosting demand for primary cells. Additionally, the expansion of research activities in fields such as cancer, immunology, and neuroscience is contributing to market growth, as primary cells are essential for studying these complex biological systems. The growing availability of high-quality primary cells from commercial suppliers, coupled with the increasing use of advanced culture systems, is also supporting market expansion. These factors, combined with continuous innovation in cell culture technologies, are driving the sustained growth of the primary cells market.

Select Competitors (Total 22 Featured) -

Allcells LLC
American Type Culture Collection (ATCC)
Axol Bioscience Ltd.
Cell Biologics, Inc.
Lonza Group AG
Merck KgaA
Promocell GmbH
Thermo Fisher Scientific, Inc.
Zenbio, Inc.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Global Economic Update
- Primary Cells - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Advancements in 3D Cell Culture Technology Propel Growth in Primary Cells Market
- Increasing Investment in Stem Cell Research Expands Addressable Market Opportunity
- CRISPR-Cas9 Technology Adoption Strengthens Business Case for Primary Cells
- Growing Focus on Regenerative Medicine Drives Demand for Animal Primary Cells
- Advancements in Biopharmaceuticals Accelerate Demand for Human Primary Cells
- Expansion of Life Science Research Companies Generates Demand for High-Quality Primary Cells
- Innovations in Cell Preservation Techniques Strengthen Business Case for Primary Cell Usage
- Emergence of Organoid Technology Drives Adoption of Primary Cells in Cancer Research
- Rising Prevalence of Chronic Diseases Expands Addressable Market for Primary Cells
- Increasing Use of Primary Cells in Toxicology Testing Expands Market Opportunities
- Growing Complexity of Drug Discovery and Development Generates Demand for Primary Cells
- Technological Integration with High-Throughput Screening Expands Market Opportunity
- Advancements in Immuno-oncology Research Propel Growth in Primary Cells Market
- Adoption of Next-Generation Sequencing (NGS) Techniques in Primary Cell Research Expands Market Opportunities
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Primary Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 2: World Historic Review for Primary Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 3: World 16-Year Perspective for Primary Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Human Primary Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 5: World Historic Review for Human Primary Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 6: World 16-Year Perspective for Human Primary Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 7: World Recent Past, Current & Future Analysis for Animal Primary Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 8: World Historic Review for Animal Primary Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 9: World 16-Year Perspective for Animal Primary Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 10: World Recent Past, Current & Future Analysis for Life Science Research Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 11: World Historic Review for Life Science Research Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 12: World 16-Year Perspective for Life Science Research Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 13: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 14: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 15: World 16-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 16: World Primary Cells Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES
- Primary Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- TABLE 17: USA Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 18: USA Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 19: USA 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
- TABLE 20: USA Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 21: USA Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 22: USA 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
CANADA
- TABLE 23: Canada Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 24: Canada Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 25: Canada 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
- TABLE 26: Canada Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 27: Canada Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 28: Canada 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
JAPAN
- Primary Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- TABLE 29: Japan Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 30: Japan Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 31: Japan 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
- TABLE 32: Japan Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 33: Japan Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 34: Japan 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
CHINA
- Primary Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- TABLE 35: China Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 36: China Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 37: China 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
- TABLE 38: China Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 39: China Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 40: China 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
EUROPE
- Primary Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 41: Europe Recent Past, Current & Future Analysis for Primary Cells by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 42: Europe Historic Review for Primary Cells by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 43: Europe 16-Year Perspective for Primary Cells by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
- TABLE 44: Europe Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 45: Europe Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 46: Europe 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
- TABLE 47: Europe Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 48: Europe Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 49: Europe 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
FRANCE
- Primary Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- TABLE 50: France Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 51: France Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 52: France 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
- TABLE 53: France Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 54: France Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 55: France 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
GERMANY
- Primary Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- TABLE 56: Germany Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 57: Germany Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 58: Germany 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
- TABLE 59: Germany Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 60: Germany Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 61: Germany 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
ITALY
- TABLE 62: Italy Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 63: Italy Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 64: Italy 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
- TABLE 65: Italy Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 66: Italy Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 67: Italy 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Primary Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- TABLE 68: UK Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 69: UK Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 70: UK 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
- TABLE 71: UK Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 72: UK Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 73: UK 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
REST OF EUROPE
- TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 75: Rest of Europe Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 76: Rest of Europe 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
- TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 78: Rest of Europe Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 79: Rest of Europe 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Primary Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 81: Asia-Pacific Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 82: Asia-Pacific 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
- TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 84: Asia-Pacific Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 85: Asia-Pacific 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
REST OF WORLD
- TABLE 86: Rest of World Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 87: Rest of World Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 88: Rest of World 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
- TABLE 89: Rest of World Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 90: Rest of World Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 91: Rest of World 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030